Results, with the caveats attached.
Every number on this page is real and defensible in writing. Where a result has more than one cause, I say so before you have to ask.
The engine and the multiplier
A 10-location SMO brought me in to run their budget and CTA negotiations. The year before, they earned $900K. That first year, they earned $3.4M.
The renegotiated budgets funded new locations. They now run more than 20 locations earning $400K to $600K per month. Sponsors awarded the studies. Their teams enrolled the patients. The negotiation made the economics work.
What a negotiated CTA can be worth
Overhead is not a fixed number. I push for the highest rate each client's financials support. Per-patient value depends on study design and indication. Where those support it, my negotiations have closed above $100K per patient. Counting every subject a site can enroll, a single CTA can exceed $1 million in value. Numbers like these do not come from a sponsor's template.
One site, built from zero
The PI had never run a study. The site did not exist. I built it from the ground up: SOPs, training, equipment lists, hiring, and sponsor introductions. Then I found the one trial that fit their patient population and negotiated its budget and CTA line by line. That site became a high enroller. The single study started at $70K per month and grew to $100K per month.
Across sprint engagements, the study award rate is near 100 percent once a formal qualification inquiry is received. Study award is sponsor-controlled and never guaranteed.
The track record behind the work
- 46+ site and SMO clients, plus three sponsor and CRO clients.
- 14 years of site-side budget and CTA negotiation.
- Sponsor-side roles at Edwards Lifesciences and Microvention (Terumo).
- Founder of two research sites. Both exited.
- Founder of Lombere Industries and Aurora Negotiator.